Recent progress and market analysis of anticoagulant drugs

被引：36
|
作者：
Fan, Ping [1 ]
Gao, Yangyang [1 ]
Zheng, Minglin [1 ]
Xu, Ting [1 ]
Schoenhagen, Paul [2 ]
Jin, Zhaohui [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Dept Pharm, Chengdu 610041, Sichuan, Peoples R China
[2] Cleveland Clin, Imaging Inst, Cleveland, OH 44195 USA
来源：
JOURNAL OF THORACIC DISEASE | 2018年 / 10卷 / 03期
关键词：
Thromboembolic disease; anticoagulant drugs; epidemiology; market situation; development trend; PERCUTANEOUS CORONARY INTERVENTION; MOLECULAR-WEIGHT HEPARIN; VENOUS THROMBOEMBOLISM; PLATELET-AGGREGATION; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; RECEPTOR ANTAGONISM; ATRIAL-FIBRILLATION; CLINICAL-PRACTICE; DOSE CLOPIDOGREL;
D O I：
10.21037/jtd.2018.03.95
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
This review describes epidemiology of thromboembolic disease in China and abroad, evaluates trends in the development of anticoagulant drugs, and analyzes the market situation based on large amounts of accumulated data. Specifically, we describe advances in clinical application of anticoagulants and analyze the most commonly used anticoagulants in the market systematically.
引用
收藏
页码：2011 / 2025
页数：15
相关论文
共 50 条
  • [31] Gastrointestinal Bleeding and Anticoagulant or Antiplatelet Drugs: Systematic Search for Clinical Practice Guidelines
    Gutermann, Irit Kaye
    Niggemeier, Verena
    Zimmerli, Lukas U.
    Holzer, Barbara M.
    Battegay, Edouard
    Scharl, Michael
    MEDICINE, 2015, 94 (01) : e377
  • [32] Anticoagulant and antithrombotic drugs in pregnancy: what are the anesthetic implications for labor and cesarean delivery?
    Butwick, A. J.
    Carvalho, B.
    JOURNAL OF PERINATOLOGY, 2011, 31 (02) : 73 - 84
  • [33] Reversal of anticoagulant drugs in case of brain haemorrhage
    Ihle-Hansen, Hakon
    Hagberg, Gun
    Sandset, Else Charlotte
    Ihle-Hansen, Hege
    KoldbergAmundsen, Erik
    Sandset, Per Morten
    Myrstad, Marius
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (14) : 1363 - 1366
  • [34] The New Anticoagulant Drugs: Are They Really Superior to Warfarin?
    Thomopoulos, Costas
    Tsioufis, Costas
    JOURNAL OF CLINICAL HYPERTENSION, 2012, 14 (10) : 727 - 727
  • [35] COVID-19, THROMBOTIC COMPLICATIONS AND ANTICOAGULANT DRUGS: AN OVERVIEW AND PHARMACOLOGICAL PERSPECTIVES
    Batista, L. A. N. C.
    Rocha, H. A. O.
    HOLOS, 2021, 37 (04)
  • [36] Effects of anticoagulant drugs on wound healing process in a rat model: a comparative study
    Cevirme, Deniz
    Savluk, Omer Faruk
    Basaran, Eylul Kafali
    Aksoy, Rezzan
    Elibol, Ahmet
    Bas, Tolga
    Elibol, Ahmet
    Keser, Sevinc
    Adademir, Taylan
    Yilmaz, Bayram
    JOURNAL OF WOUND CARE, 2020, 29 (01) : 44 - +
  • [37] Recent progress, pacemaker
    Hayashi, Hiroshi
    Shimizu, Wataru
    JAPANESE JOURNAL OF ARTIFICIAL ORGANS, 2020, 49 (03):
  • [38] Primary Prevention of Ischaemic Stroke in Atrial Fibrillation: New Oral Anticoagulant Drugs for all?
    Foley, James
    Kirchhof, Paulus
    Lip, Gregory Y. H.
    CURRENT VASCULAR PHARMACOLOGY, 2014, 12 (03) : 373 - 383
  • [39] Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland
    Labuz-Roszak, Beata
    Pierzchala, Krystyna
    Skrzypek, Michal
    Swiech, Marta
    Machowska-Majchrzak, Agnieszka
    BMC CARDIOVASCULAR DISORDERS, 2012, 12
  • [40] Popular naturally occurring antioxidants as potential anticoagulant drugs
    Bijak, Michal
    Saluk, Joanna
    Szelenberger, Rafal
    Nowak, Pawel
    CHEMICO-BIOLOGICAL INTERACTIONS, 2016, 257 : 35 - 45
12345